Specimen Validity Testing Market Report 2025 – For Visionary Product and Strategy Executives

 Unlock 30% off global market reports with code ONLINE30 — get insights on tariff changes, macro trends, and global economic shifts.

 

 What is the projected market size of the specimen validity testing industry, and what is its expected CAGR?
 The specimen validity testing market size has grown strongly in recent years. It will grow from $3.68 billion in 2024 to $4.03 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing drug adoption, increased drug screening, stringent regulations, increased alcohol use, and integration of point-of-care testing.
 
 The specimen validity testing market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising demand for workplace drug testing, growing adoption of oral fluid testing, rise in research and development operations, rising usage of SVTand expanding applications in pain management. Major trends in the forecast period include technological advancements, integration of artificial intelligence for result interpretation, product innovations, increasing partnerships, and the development of portable testing devices for on-the-go monitoring.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=15673&type=smp
 
 What external factors are influencing the specimen validity testing market’s growth momentum?
 The increased drug abuse is expected to propel the growth of the specimen validity testing market going forward. Drug abuse refers to the customary, excessive, or inappropriate use of legal or illegal substances for non-medical purposes. Drug abuse is increasing due to several interconnected factors, such as the opioid habit, developing mental health issues, barriers to treatment and support resources, and cultural depictions. SVT methods are developed to identify the presence of impurities and compounds by examining several parameters such as pH, specific gravity, creatinine content, and temperature. For instance, in October 2023, according to the Office for Health Improvement and Disparities, a UK-based government department, adult contacts with drug and alcohol programs rose from April 2021 to March 2022, totaling 0.29 million interactions, up from 0.28 million the year prior. Additionally, in October 2024, according to the Office for National Statistics, a UK-based government agency, in 2023, England and Wales recorded 5,448 drug poisoning-related deaths, marking an 11.0% increase from the 4,907 deaths registered in 2022. Therefore, the increased drug abuse is expected to propel the growth of the specimen validity testing market.
 
 What are the major market segments driving the growth of the specimen validity testing industry?
 The specimen validity testing market covered in this report is segmented –
 
 1) By Product And Service: Products, Service
 2) By Testing Type: Laboratory Testing, Rapid Or Point-Of-Care Testing
 3) By End-User: Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Criminal Justice And Law Enforcement Agencies, Other End-Users
 
 Subsegments:
 1) By Products: Reagents And Assay Kits, Controls And Calibrators, Specimen Collection Devices, Analyzers And Instruments
 2) By Service: Laboratory Testing Services, Point-Of-Care Testing Services
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/specimen-validity-testing-global-market-report
 
 What technological trends are expected to redefine the specimen validity testing market?
 Major companies operating in the specimen validity testing market are developing innovative products such as high-resolution urine drug testing profiles, to sustain their position in the market. A high-resolution urine drug testing profile is a sophisticated testing method with advanced analytical techniques. For instance, in July 2022, Mayo Clinic Laboratories, a US-based medical laboratory, launched a data-driven urine drug testing (UDT) profile to equip physicians with the necessary information for managing patients with addiction to common substances like prescription opioids, alcohol, marijuana, and nicotine. This new addiction medicine monitoring profile (Mayo ID ADMPU) aligns with the American Society of Addiction Medicine’s guidelines. It offers enhanced sensitivity and specificity to identify parent drugs and metabolites from various drug classes, including opioids, benzodiazepines, stimulants, and PCP. The profile utilizes high-resolution, accurate mass spectrometry for targeted and immunoassay testing for specific substances, providing comprehensive and clinically relevant information for healthcare providers.
 
 Who are the key market players contributing to the growth of the specimen validity testing industry?
 Major companies operating in the specimen validity testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Medline Industries Inc., Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., Clinical Reference Laboratory Inc., Precision Diagnostics, ACM Global Laboratories, Millennium Health, Omega Laboratories Inc., Dominion Diagnostics, CannAmm, Sciteck Inc., Starplex Scientific Inc., Vision Diagnostics Inc., Premier Biotech Inc., Alfa Scientific Designs, Express Diagnostics, American Bio Medica Corporation, Titan Biotech Ltd., SureHire, Miraclean Technology Co. Ltd
 
 Which regions are leading the growth of the specimen validity testing market globally?
 North America was the largest region in the specimen validity testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specimen validity testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 How Can Companies Use The Specimen Validity Testing Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15673
 
 Need Customized Data On Specimen Validity Testing Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=15673&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Americas +1 310–496-7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267
 Email us at info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company